Recent Insider Activity Suggests Potential Gains for Athira Pharma Inc (ATHA)
Athira Pharma Inc’s recently made public that its Chief Executive Officer Litton Mark James unloaded Company’s shares for reported $14026.0 on Jan 05 ’24. In the deal valued at $2.91 per share,4,820 shares were sold. As a result of this transaction, Litton Mark James now holds 144,397 shares worth roughly $0.4 million. Then, Worthington Mark […]
